Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

June
09
2026

Is There an Alternative to Mohs Surgery for Non-Melanoma Skin Cancer?

Receiving a non-melanoma skin cancer diagnosis can feel stressful. In fact, studies show that more than one in three patients find the diagnosis traumatic, with many more experiencing anxiety about what comes next. For many,…

September
17
2021

Colorado Dermatological Society

Join Sensus Healthcare at the Colorado Dermatological Society at the Hilton Denver Inverness!

September
08
2021

Sensus Healthcare to Participate at H.C. Wainwright 23rd Annual Global Investment Conference

Boca Raton, Fla., Sept. 08, 2021 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announced that Joe Sardano, chairman…

August
26
2021

SRT Effectively Addresses NMSC, Keloids

Superficial radiation therapy (SRT) greatly reduces keloid recurrence rates and, for keratinocytic skin cancers, provides short-term cure rates similar to those in previous SRT research and of surgical options including Mohs surgery, Brian Berman, MD,…

August
25
2021

Avoid Basal Cell Carcinoma Removal Scar with SRT

If you’ve been diagnosed with Basal Cell Carcinoma (BCC), you are not alone. BCC is the most common form of skin cancer, with an estimated 3.6 million cases diagnosed every year in the U.S. alone….

Archives
Archives

IN THE NEWS

From Scalpel to SRT: Impact of Innovation on the Dermatology Industry